№ files_lp_4_process_2_60917
File format: docx
Character count: 39859
File size: 122 KB
Research article reporting on the development and validation of a protein microarray to profile immunoglobulin E responses in horses with severe equine asthma, identifying novel environmental allergens and comparing serum and bronchoalveolar lavage fluid results.
Year:
2026
Region / City:
United Kingdom
Topic:
Veterinary Immunology / Equine Asthma
Document Type:
Research Article
Institution:
University Veterinary Research Center
Authors:
[Not specified in document]
Target Audience:
Veterinary researchers, equine clinicians
Study Period:
Not explicitly stated
Sample Size:
12 horses (6 sEA-affected, 6 healthy controls)
Methodology:
Protein microarray-based IgE profiling
Key Findings:
Identification of novel allergens associated with severe equine asthma, reproducibility and specificity of microarray validated
Price: 8 / 10 USD
The file will be delivered to the email address provided at checkout within 12 hours.
The file will be delivered to the email address provided at checkout within 12 hours.
Don’t have cryptocurrency yet?
You can still complete your purchase in a few minutes:- Buy Crypto in a trusted app (Coinbase, Kraken, Cash App or any similar service).
- In the app, tap Send.
- Select network, paste our wallet address.
- Send the exact amount shown above.
The final amount may vary slightly depending on the payment method.
The file will be sent to the email address provided at checkout within 24 hours.
The product description is provided for reference. Actual content and formatting may differ slightly.
Version:
V3.0
Author:
Dr Julia Sikorska, Consultant Haematologist, STSTN Clinical Guidelines Group
Note:
2019
Executive/Divisional sponsor:
Via Hospital Transfusion Committee
Applies to:
All staff involved in the care of patients with Sickle Cell Disease
Date issued:
V3.0 February 2020
Review date:
February 2023
Approval person/Committee:
Hospital Transfusion Committee
Date:
March 2020
Year:
2020
Region / city:
St George’s, UK
Topic:
Hyperhaemolysis management in Haemoglobinopathies
Document type:
Clinical guidelines
Organization / institution:
St George’s University Hospitals NHS
Target audience:
Healthcare staff involved in the care of Sickle Cell Disease patients
Effective period:
February 2020–February 2023
Approval date:
March 2020
Year:
2024
Region / city:
Canberra
Topic:
Immunology, Blood Products
Document Type:
Procedure
Organization / Institution:
Canberra Health Services
Author:
Not specified
Target Audience:
Medical Officers, Nurses, Midwives, Students under direct supervision
Period of validity:
Not specified
Approval Date:
Not specified
Date of Changes:
Not specified
Year:
2026
Region / City:
Australia
Theme:
Medical Travel, Blood Products, SCIg
Document Type:
Official Guidelines
Organization / Institution:
Australian Red Cross Lifeblood, National Blood Authority, Victorian Government Department of Health
Author:
Victorian Government, Department of Health
Target Audience:
Medical professionals, Patients requiring SCIg
Period of Validity:
Not specified
Date of Approval:
January 2026
Date of Last Update:
January 2026
Year:
2023
Country:
Australia
Document type:
Clinical guidance
Organization:
Australian Government Department of Health / Blood Service
Target audience:
Healthcare professionals administering IVIg
Scope:
IVIg administration, safety, and monitoring
Effective from:
April 2023
References:
Criteria for the clinical use of intravenous immunoglobulin in Australia, 3rd edition, October 2018; Product information sheets of Privigen®AU, Kiovig®, Flebogamma®, Gammunex®, Octagam®
Appendices:
Product comparison, infusion rate guides
Date:
March 2023
Country:
Australia
Subject:
Intravenous immunoglobulin administration
Document type:
Clinical practice guidance
Healthcare setting:
Hospital and health services
Target audience:
Healthcare professionals involved in IVIg prescribing and administration
Regulatory context:
BloodSTAR authorization and national IVIg criteria
Products referenced:
Privigen®, Kiovig®, Flebogamma®, Gammunex®, Octagam®, Intragam®10
Effective period:
From April 2023
Clinical scope:
Indications, precautions, preparation, infusion, storage, and adverse effects
Source type:
Official guidance
Year:
Not specified
Region / City:
Not specified
Subject:
Tetanus prevention, immunization, post-exposure prophylaxis
Document Type:
Medical guideline
Organization / Institution:
Not specified
Author:
Not specified
Target Audience:
Healthcare professionals, medical practitioners
Period of validity:
Not specified
Approval Date:
Not specified
Date of Changes:
Not specified
Year:
2004-2016
Region / City:
Queensland, Australia
Topic:
Public health, immunoglobulin use
Document Type:
Research paper
Organization / Institution:
Griffith University, The Prince Charles Hospital, National Blood Authority
Author:
Megan K Young, Allan W Cripps, Graeme R Nimmo
Target Audience:
Public health professionals, researchers
Effective Period:
2004-2016
Approval Date:
N/A
Date of Revisions:
N/A
Year:
2026
Region / City:
United Kingdom
Subject:
Perinatal Hepatitis B Prevention
Document Type:
Medical Request Form
Institution:
NHS
Author:
Healthcare Practitioner
Target Audience:
Hospital staff and pharmacists
Period of Use:
Antenatal and postnatal period
Date of Issue:
2026
Instructions Included:
Yes
Emergency Procedures:
Yes
Vaccine Administration Guidelines:
Yes
Maternal Antiviral Treatment Recorded:
Yes
Infant Delivery and Health Data:
Yes
Form Submission Method:
Email
Year:
2026
Region / City:
Western Australia
Subject:
Public Health, Rabies Immunoglobulin Supply
Document Type:
Guidelines, Information for Doctors
Organization:
Government of Western Australia, Department of Health
Author:
Department of Health, Public Health and Clinical Services, Communicable Disease Control Directorate
Target Audience:
Public Health Units, On-call Doctors
Period of Validity:
Ongoing
Approval Date:
Not specified
Amendment Date:
Not specified
Year:
2023
Region / city:
Madison, Wisconsin
Subject:
Veterinary medicine, cardiology, clinical trial
Document type:
Consent form
Institution:
University of Wisconsin-Madison, UW Veterinary Care
Authors:
Angela Molli, DVM; Sonja Tjostheim, DVM, DACVIM (Cardiology)
Target audience:
Horse owners, veterinary professionals
Duration:
Not specified
Approval date:
Not specified
Date of changes:
Not specified
Confidentiality:
Yes
Risk information:
No risks associated with study
Procedure details:
Cardiopulmonary exam, echocardiography, ECG
Financial obligations:
Owner responsible for non-study related costs
Compensation:
None for accidental injury or complications
Contextual description:
Consent form for participation in a clinical study involving American Quarter Horses, aimed at establishing echocardiographic reference ranges.
Version:
1.0
Release Date:
10 November 2017
Year:
2017
Note:
Region / City
Theme:
Legal, Horse Leasing
Document Type:
Contract
Organ / Institution:
Norris Ward McKinnon Lawyers (NWM)
Target Audience:
Horse owners, lessees, legal professionals
Context:
A legal document outlining the terms of a lease agreement for a horse between the owner and the lessee, including rental terms, horse details, and obligations of both parties.
Year:
2023
Region / Country:
United States
Subject:
Contagious equine metritis (Taylorella equigenitalis)
Document type:
Veterinary regulation / guideline
Authority:
Terrestrial Animal Health Code Committee
Target audience:
Veterinary Authorities, horse breeders, import/export officials
Period of validity:
Permanent unless updated
Date of publication:
2023
Relevant articles:
12.2.1–12.2.5
Note:
Year
Note:
Year
Organization / institution:
Parks Victoria
Context:
A document outlining the criteria and process for applying to rehome feral horses through Parks Victoria.
Certificate number:
7500EHC
Subject:
Export of horses returning to Guatemala via the Netherlands after the World Endurance Championships in London 2012
Type of document:
Official guidance notes
Related event:
World Endurance Championships
Issuing authority:
Department for Environment, Food and Rural Affairs
Associated authorities:
Scottish Government – Rural Directorate; Welsh Government – Department for Rural Affairs; Department of Agriculture and Rural Development Northern Ireland
Geographical scope:
United Kingdom; Guatemala; Netherlands
Responsible officials:
Official Veterinarians (OV); Authorised Veterinary Inspectors (AVI)
Related body:
Animal Health and Veterinary Laboratories Agency Specialist Service Centre – Exports, Carlisle
Validity conditions:
Inspection within 48 hours prior to shipment
Disease requirements:
Freedom from FMD and notifiable equine diseases in the UK during the previous 5 days
Additional requirements:
Compliance with British export welfare legislation
Year:
2026
Region / City:
Not specified
Subject:
Equestrian event results
Document type:
Event results
Organization / Institution:
NCPA
Author:
Not specified
Target audience:
Equestrian community
Period of validity:
Not specified
Approval date:
Not specified
Date of changes:
Not specified
Year:
2023
Region / City:
Australia
Subject:
Racing Industry, Horse Training
Document Type:
Unit of Competency
Organization:
Racing Training Package
Author:
Not specified
Target Audience:
Individuals working under supervision in the racing industry
Period of Validity:
Not specified
Approval Date:
Not specified
Amendment Date:
Not specified
Year:
2023
Region / City:
United States
Topic:
Horseracing, Constitutional Law, Federal Legislation
Document Type:
Legal Note
Institution:
Oklahoma City University Law Review
Author:
Kalen Youtsey
Target Audience:
Legal professionals, academics, horseracing industry stakeholders
Period of Effect:
Ongoing
Date of Approval:
2020
Date of Amendments:
N/A
Context:
Legal analysis of the Horseracing Integrity and Safety Act (HISA) and its constitutional challenges, with a focus on state and federal regulations of horseracing in the United States.
Year:
2023
Region / City:
United States
Subject:
English Language Arts
Document Type:
Lesson Plan
Author:
Curriculum Designer / Publisher
Intended Audience:
Grade 5 Students and Teachers
Suggested Duration:
5 days (45 minutes per day)
Standards:
Common Core ELA RL.5.1, RL.5.2, RL.5.4, RL.5.10; RF.5.3, RF.5.4; W.5.2, W.5.4; SL.5.1; L.5.1, L.5.2, L.5.4, L.5.5
Content Focus:
Reading comprehension, critical thinking, vocabulary, character analysis
Teaching Methods:
Independent reading, guided reading, discussion, text-dependent questioning, group work
Core Themes:
Patience, perseverance, observation, interaction with nature
Main Character:
Bob Lemmons, African American cowboy
Setting:
Ranch and wild plains with mustangs
Learning Objectives:
Identify key ideas, understand character traits, interpret similes and metaphors, analyze narrative events